Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.

Robert Mróz(Medical University of Białystok), William MacNee(The Queen's Medical Research Institute), Joanna B. Bierła(Children's Memorial Health Institute), Piotr Boros, Robert Milewski, Łukasz Minarowski, A. M. Duszewska, E Chyczewska, Paulina Trzeciak, Paweł Lisowski(Max Delbrück Center), Anna Lisowska, Agnieszka Tycińska, Włodzimierz J. Musiał, Bożena Sobkowicz

PubMed

February 1, 2015

Cited by 56

Related Papers

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

|European Respiratory Journal|2004|4.4k

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

|New England Journal of Medicine|2010|3k

Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD

|American Journal of Respiratory and Critical Care Medicine|2010|1k

Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure

|Particle and Fibre Toxicology|2005|929

Oxidative stress and regulation of glutathione in lung inflammation

|European Respiratory Journal|2000|913